SCHEMBL14372263

SCHEMBL14372263

CCCC(C)c1ccc(-c2ccc(C(=O)Nc3cccc(C)c3)cc2)nc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 5/20 0.50
▸ KMT2A Q03164 5/20 0.50
▸ SMN1; SMN2 Q16637 3/20 0.50
▸ ALDH1A1 P00352 2/20 0.50
▸ LMNA P02545 1/20 0.50
▸ SCN2A Q99250 2/20 0.46
▸ SCN10A Q9Y5Y9 2/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ TP53 P04637 1/20 0.46
▸ NFKB1 P19838 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ NFKB2 Q00653 1/20 0.46
▸ RELA Q04206 1/20 0.46
▸ RXFP1 Q9HBX9 1/20 0.45
▸ NPSR1 Q6W5P4 2/20 0.45
▸ MAPT P10636 2/20 0.45
▸ HTT P42858 1/20 0.45
▸ PTPN1 P18031 2/20 0.44
▸ PTPN2 P17706 1/20 0.44
▸ PTPN6 P29350 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12136827 0.87 MAPT (0.47) MEN1KMT2ARXFP1MAPTKCNK3
SCHEMBL12136828 0.84 RAB9A (0.46) MEN1KMT2ASMN1; SMN2ALDH1A1LMNA
SCHEMBL12136829 0.82 MEN1 (0.48) MEN1KMT2ASMN1; SMN2LMNANPC1
SCHEMBL12136826 0.77 RXFP1 (0.50) MEN1KMT2ANPC1TP53RAB9A
SCHEMBL16495590 0.77 MEN1 (0.70) MEN1KMT2ASMN1; SMN2ALDH1A1LMNA
SCHEMBL5934348 0.72 SMN1; SMN2 (0.53) MEN1KMT2ASMN1; SMN2ALDH1A1LMNA
SCHEMBL14083010 0.71 NPC1 (0.52) KMT2ASMN1; SMN2ALDH1A1SCN2ASCN10A
SCHEMBL5934465 0.70 ROCK2 (0.58) KMT2ASMN1; SMN2ALDH1A1NPC1TP53
SCHEMBL10090678 0.70 KMT2A (0.72) MEN1KMT2ASMN1; SMN2ALDH1A1LMNA
SCHEMBL14083014 0.70 RAB9A (0.55) MEN1KMT2ASMN1; SMN2ALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070232661-A1 Hedgehog Pathway Antagonists NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2007-10-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232661-A1 Hedgehog Pathway Antagonists GLI1, SHH, SMO MEN1 2398/4885KMT2A 944/4885SMN1; SMN2 2484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback